Researches have shown that BRAFi + MEKi treatment induces caspase-3 activation and increases cleavage of caspase-3, which promotes the production of the 35 kDa GSDME cleavage fragment in mouse and human melanoma cells42. This evidence concerns the gene GSDME and melanoma.